World Health Organization Issues Prequalification Of BD FACSPresto Near-Patient CD4 Counter System For HIV/AIDS Monitoring

By: via Benzinga
BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.